Basiliximab

Simulect

Treatment Description

Basiliximab is a monoclonal antibody that is FDA approved for use in kidney transplant patients to help prevent rejection. It is being studied for use in several other different indications both by itself, and in combination with radioactive isotopes.

Participating Centers

There is one center running trials with this treatment. Enter a location below to view the distance.